GWAS-Linked Loci and Neuroimaging Measures in Alzheimer's Disease. (Q46013803)

18 December 2017

title

GWAS-Linked Loci and Neuroimaging Measures in Alzheimer's Disease. (English)

1 reference

18 December 2017

genome-wide association study

main subject

neuroimaging

0 references

Alzheimer's disease

0 references

1 reference

based on heuristic

inferred from title

author

Alzheimer's Disease Neuroimaging Initiative

10

object named as

Alzheimer’s Disease Neuroimaging Initiative

1 reference

18 December 2017

Jin-Tai Yu

9

0 references

Lan Tan

8

object named as

Lan Tan

1 reference

18 December 2017

7

Teng Jiang

1 reference

18 December 2017

author name string

Jie-Qiong Li

1

1 reference

18 December 2017

Hui-Fu Wang

2

1 reference

18 December 2017

Xi-Chen Zhu

3

1 reference

18 December 2017

Fu-Rong Sun

4

1 reference

18 December 2017

Meng-Shan Tan

5

1 reference

18 December 2017

Chen-Chen Tan

6

1 reference

18 December 2017

publication date

5 January 2016

1 reference

18 December 2017

published in

Molecular Neurobiology

1 reference

18 December 2017

volume

54

1 reference

18 December 2017

page(s)

146-153

1 reference

18 December 2017

issue

1

1 reference

18 December 2017

https://scigraph.springernature.com/pub.10.1007/s12035-015-9669-1

exact match

0 references

cites work

Novel disease-modifying therapies for Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9669-1

Genome-Wide Association Studies in Alzheimer Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9669-1

APOE and Alzheimer disease: a major gene with semi-dominant inheritance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9669-1

Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9669-1

PET imaging of brain amyloid in dementia: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9669-1

The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9669-1

Association of white matter hyperintensity measurements on brain MR imaging with cognitive status, medial temporal atrophy, and cardiovascular risk factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9669-1

A comprehensive study of gray matter loss in patients with Alzheimer's disease using optimized voxel-based morphometry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9669-1

Voxel-based assessment of gray and white matter volumes in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9669-1

Hippocampal atrophy rates in Alzheimer disease: added value over whole brain volume measures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9669-1

Age, Alzheimer disease, and brain structure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9669-1

Neuroimaging biomarkers of neurodegenerative diseases and dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9669-1

The Alzheimer's Disease Neuroimaging Initiative (ADNI): MRI methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9669-1

Associations between cognitive, functional, and FDG-PET measures of decline in AD and MCI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9669-1

Genetic variation and neuroimaging measures in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9669-1

Loss of apolipoprotein E receptor LR11 in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9669-1

SORL1 is genetically associated with late-onset Alzheimer's disease in Japanese, Koreans and Caucasians

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9669-1

Genome-wide association study implicates a chromosome 12 risk locus for late-onset Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9669-1

Structural MRI biomarkers for preclinical and mild Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9669-1

Combining MR imaging, positron-emission tomography, and CSF biomarkers in the diagnosis and prognosis of Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9669-1

Bridging Integrator 1 (BIN1) Genotype Effects on Working Memory, Hippocampal Volume, and Functional Connectivity in Young Healthy Individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9669-1

Alzheimer's disease susceptibility variants in the MS4A6A gene are associated with altered levels of MS4A6A expression in blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9669-1

Overrepresentation of glutamate signaling in Alzheimer's disease: network-based pathway enrichment using meta-analysis of genome-wide association studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9669-1

Complement receptor 1 (CR1) and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9669-1

Multilocus genetic profiling to empower drug trials and predict brain atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9669-1

An Updated Analysis with 85,939 Samples Confirms the Association Between CR1 rs6656401 Polymorphism and Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9669-1

10.1007/S12035-015-9669-1

21 January 2018

Identifiers

DOI

1 reference

18 December 2017

PubMed ID

26732597

1 reference

18 December 2017